Nuclear matrix protein expression in prostate cancer: Possible prognostic and diagnostic applications

Paola Barboro, Alessandra Rubagotti, Francesco Boccardo, Barbara Carnemolla, Cristina D'Arrigo, Eligio Patrone, Cecilia Balbi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Different lines of evidence suggest that the nuclear matrix (NM), the protein scaffold of the nucleus, represents a functional unit playing a pivotal role in the spatial and temporal coordination of the events of gene activation. Any change in the gene expression pattern, which occurs during carcinogenesis, may partially depend on an impairment of the regulatory functions of the NM. Therefore, increasing interest has been addressed to the study of NM modifications associated with malignant transformations and to potential clinical applications. Here, recent results on the NM changes in prostate cancer are discussed. Tumor cells are characterized by a more complex NM protein pattern compared to normal tissue: the development of poorly-differentiated tumors is characterized by the expression of proteins that are not present in hyperplastic tissues or in more differentiated tumors. In addition, a few newly-expressed proteins are significantly correlated with the risk of biochemical progression. The potential application of these proteins at the diagnostic and prognostic levels calls for further studies.

Original languageEnglish
Pages (from-to)3999-4004
Number of pages6
JournalAnticancer Research
Volume25
Issue number6 B
Publication statusPublished - Nov 2005

Fingerprint

Nuclear Matrix-Associated Proteins
Nuclear Matrix
Prostatic Neoplasms
Neoplasms
Proteins
Transcriptional Activation
Carcinogenesis
Gene Expression

Keywords

  • Diagnostic and prognostic markers
  • Nuclear matrix
  • Prostate cancer
  • Review

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Barboro, P., Rubagotti, A., Boccardo, F., Carnemolla, B., D'Arrigo, C., Patrone, E., & Balbi, C. (2005). Nuclear matrix protein expression in prostate cancer: Possible prognostic and diagnostic applications. Anticancer Research, 25(6 B), 3999-4004.

Nuclear matrix protein expression in prostate cancer : Possible prognostic and diagnostic applications. / Barboro, Paola; Rubagotti, Alessandra; Boccardo, Francesco; Carnemolla, Barbara; D'Arrigo, Cristina; Patrone, Eligio; Balbi, Cecilia.

In: Anticancer Research, Vol. 25, No. 6 B, 11.2005, p. 3999-4004.

Research output: Contribution to journalArticle

Barboro, P, Rubagotti, A, Boccardo, F, Carnemolla, B, D'Arrigo, C, Patrone, E & Balbi, C 2005, 'Nuclear matrix protein expression in prostate cancer: Possible prognostic and diagnostic applications', Anticancer Research, vol. 25, no. 6 B, pp. 3999-4004.
Barboro P, Rubagotti A, Boccardo F, Carnemolla B, D'Arrigo C, Patrone E et al. Nuclear matrix protein expression in prostate cancer: Possible prognostic and diagnostic applications. Anticancer Research. 2005 Nov;25(6 B):3999-4004.
Barboro, Paola ; Rubagotti, Alessandra ; Boccardo, Francesco ; Carnemolla, Barbara ; D'Arrigo, Cristina ; Patrone, Eligio ; Balbi, Cecilia. / Nuclear matrix protein expression in prostate cancer : Possible prognostic and diagnostic applications. In: Anticancer Research. 2005 ; Vol. 25, No. 6 B. pp. 3999-4004.
@article{32b087f528a7462d9b359a26bf33fac6,
title = "Nuclear matrix protein expression in prostate cancer: Possible prognostic and diagnostic applications",
abstract = "Different lines of evidence suggest that the nuclear matrix (NM), the protein scaffold of the nucleus, represents a functional unit playing a pivotal role in the spatial and temporal coordination of the events of gene activation. Any change in the gene expression pattern, which occurs during carcinogenesis, may partially depend on an impairment of the regulatory functions of the NM. Therefore, increasing interest has been addressed to the study of NM modifications associated with malignant transformations and to potential clinical applications. Here, recent results on the NM changes in prostate cancer are discussed. Tumor cells are characterized by a more complex NM protein pattern compared to normal tissue: the development of poorly-differentiated tumors is characterized by the expression of proteins that are not present in hyperplastic tissues or in more differentiated tumors. In addition, a few newly-expressed proteins are significantly correlated with the risk of biochemical progression. The potential application of these proteins at the diagnostic and prognostic levels calls for further studies.",
keywords = "Diagnostic and prognostic markers, Nuclear matrix, Prostate cancer, Review",
author = "Paola Barboro and Alessandra Rubagotti and Francesco Boccardo and Barbara Carnemolla and Cristina D'Arrigo and Eligio Patrone and Cecilia Balbi",
year = "2005",
month = "11",
language = "English",
volume = "25",
pages = "3999--4004",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Nuclear matrix protein expression in prostate cancer

T2 - Possible prognostic and diagnostic applications

AU - Barboro, Paola

AU - Rubagotti, Alessandra

AU - Boccardo, Francesco

AU - Carnemolla, Barbara

AU - D'Arrigo, Cristina

AU - Patrone, Eligio

AU - Balbi, Cecilia

PY - 2005/11

Y1 - 2005/11

N2 - Different lines of evidence suggest that the nuclear matrix (NM), the protein scaffold of the nucleus, represents a functional unit playing a pivotal role in the spatial and temporal coordination of the events of gene activation. Any change in the gene expression pattern, which occurs during carcinogenesis, may partially depend on an impairment of the regulatory functions of the NM. Therefore, increasing interest has been addressed to the study of NM modifications associated with malignant transformations and to potential clinical applications. Here, recent results on the NM changes in prostate cancer are discussed. Tumor cells are characterized by a more complex NM protein pattern compared to normal tissue: the development of poorly-differentiated tumors is characterized by the expression of proteins that are not present in hyperplastic tissues or in more differentiated tumors. In addition, a few newly-expressed proteins are significantly correlated with the risk of biochemical progression. The potential application of these proteins at the diagnostic and prognostic levels calls for further studies.

AB - Different lines of evidence suggest that the nuclear matrix (NM), the protein scaffold of the nucleus, represents a functional unit playing a pivotal role in the spatial and temporal coordination of the events of gene activation. Any change in the gene expression pattern, which occurs during carcinogenesis, may partially depend on an impairment of the regulatory functions of the NM. Therefore, increasing interest has been addressed to the study of NM modifications associated with malignant transformations and to potential clinical applications. Here, recent results on the NM changes in prostate cancer are discussed. Tumor cells are characterized by a more complex NM protein pattern compared to normal tissue: the development of poorly-differentiated tumors is characterized by the expression of proteins that are not present in hyperplastic tissues or in more differentiated tumors. In addition, a few newly-expressed proteins are significantly correlated with the risk of biochemical progression. The potential application of these proteins at the diagnostic and prognostic levels calls for further studies.

KW - Diagnostic and prognostic markers

KW - Nuclear matrix

KW - Prostate cancer

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=27944439233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27944439233&partnerID=8YFLogxK

M3 - Article

C2 - 16309191

AN - SCOPUS:27944439233

VL - 25

SP - 3999

EP - 4004

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -